Pharmeca.cz

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of Prices and Reimbursements for Medicinal Products and Foods for Special Medicinal Purposes (“List”).

 

Více na: EN SUKL - List of reimbursed medicinal products

 

This country note explains how the Czech Republic taxes energy use. The note shows the distribution of effective energy tax rates across all domestic energy use. It also details the country-specific assumptions made when calculating effective energy tax rates and matching tax rates to the corresponding energy base.

 

Více na: OECD.org - Czech Republic

 

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of Prices and Reimbursements for Medicinal Products and Foods for Special Medicinal Purposes (“List”).

 

Více na: EN SUKL - List of reimbursed medicinal products

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Glaxo Group Limited, against the decision of the State Institute for Drug Control from 29. 9. 2017, under the no. SUKLS182217/2017 - I. Under aricle 90 paragraph 4 in connection with article 66 paragraph 2 of the Administrative Code the operative part 19 of the decision under appeal is dismissed and the proceedings are terminated II. Under aricle 90 paragraph 5 of the Administrative Code the appeal is dismissed and the rest of the decision under appeal is upheld.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Apotex Europe B.V., Egis Pharmaceuticals PLC, Pfizer, spol. s r.o., against the decision of the State Institute for Drug Control from 24. 3. 2017, under the no. SUKLS27614/2017 - The decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Janssen-Cilag International N.V., against the decision of the State Institute for Drug Control from 24. 1. 2017, under the no. SUKLS244621/2016 - 

The decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.

More information: MZCR.cz (czech version only)

 

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of Prices and Reimbursements for Medicinal Products and Foods for Special Medicinal Purposes (“List”).

 

Více na: EN SUKL - List of reimbursed medicinal products

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Montrose Fine Chemical Company Ltd., Glaxo Group Limited, against the decision of the State Institute for Drug Control from 8. 12. 2016, under the no. SUKLS141731/2014 - I. under article 90 paragraph 4 in connection with article 66 paragraph 2 of the Administrative Code the operative part 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 17, 18, 20, 21, 23, 25, 26, 30, 32, 35 and 37 of the decision under appeal is dismissed and the proceedings are terminated. II. Under article 90 paragraph 5 of the Administrative Code the appeal is dismissed and the rest of the decision under appeal is upheld.

More information: MZCR.cz (czech version only)